BRAINSTORM CELL THERAPEUTICS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.511 EUR | +9.07% |
|
+2.61% | +122.17% |
| Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Step Down of Stacy Lindborg as Co-CEO, Effective as of May 9, 2024 | CI |
| Apr. 17 | Brainstorm Cell Therapeutics Inc. Announces Management Changes | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 54.04B | - | |||||
| 41.92B | ||||||
| 41.96B | ||||||
| 28.35B | ||||||
| 26.35B |
